Journal of translational medicine

Single-cell analysis and machine learning show unusual TIM-3 levels in brain immune cells during Alzheimer's progression

Updated

Abstract

A novel + microglial subset is identified, driving Alzheimer's disease pathology through neuroinflammation and impaired amyloid-β clearance.

  • TIM-3 + microglia sustain neuroinflammation via TNF-α/NF-κB and IL-6/JAK/STAT3 signaling pathways.
  • This microglial subset is associated with impaired amyloid-β clearance linked to PI3K-AKT and FcγR pathways.
  • Strong interactions were observed between TIM-3 + microglia and known Alzheimer's disease risk genes such as INPP5D and TREM2.
  • Machine learning analysis classified Alzheimer's patients into a 'hyper-inflammatory' subtype and a 'metabolically dysregulated' subtype, each with distinct pathological drivers.
  • Network pharmacology analysis predicted tretinoin (ATRA) as a potential therapeutic candidate targeting the CD86–PTPRC–ITGAX axis in TIM-3 + microglia.

Simplified

Key numbers

0.984
AUC of GBM model
Performance of the gradient boosting machine model in training set.
516
Total samples analyzed
Combined samples from four bulk RNA-seq datasets.
356
356 overlapping genes
Overlap between AD-associated genes and tretinoin targets.

Full Text

We can’t show the full text here under this license.

Funding

Competing interests

Declarations. Ethics approval and consent to participate: Not applicable. Consent for publication: Not applicable. Competing interests: All the authors declare that they have no competing interests.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free